Form 4: Xylem EVP Sells Over 10,000 Shares

Xylem Inc.'s EVP, Claudia S. Toussaint, reported the sale of 10,421 shares of common stock from her revocable trust at a weighted average price of $152.64 per share.

Summary

• Claudia S. Toussaint, Executive Vice President and CPSO of Xylem Inc., reported the sale of 10,421 shares of Xylem common stock.
• The shares were sold on October 30, 2025, at a weighted average price of $152.64 per share, with prices ranging from $152.51 to $152.98.
• The sale was executed from the Claudia S. Toussaint Revocable Trust, of which Ms. Toussaint is the trustee and a beneficiary.
• Following the transaction, Ms. Toussaint indirectly beneficially owns 31,250 shares through the trust and directly owns 3,939 shares.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.

Sentiment

Score: 5

Explanation: The sale is a routine insider transaction under a pre-arranged 10b5-1 plan, which mitigates any strong negative sentiment typically associated with insider sales. It's a neutral event in the context of a planned divestment.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to new, non-public information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived as a slight negative signal regarding management's confidence in the company's near-term stock price.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, which could be interpreted as a slight decrease in management's direct financial alignment, though mitigated by the 10b5-1 plan.

Key Dates

Recommendation

The transaction is a pre-planned insider sale under a Rule 10b5-1 plan, which typically does not signal a change in the company's fundamental outlook. While it reduces insider ownership, it's not indicative of new negative information. Therefore, a 'hold' recommendation is appropriate as this event alone does not warrant a change in investment thesis.

Keywords

Xylem Inc., XYL, Insider Trading, Form 4, Stock Sale, Claudia S. Toussaint, Executive Vice President, Corporate Governance, Rule 10b5-1